Company Comparison
Syros Pharmaceuticals vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Syros Pharmaceuticals | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | South San Francisco, California |
| Founded | — | 2006 |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Syros Pharmaceuticals
Clinical-stage biotech developing cancer treatments by controlling gene expression using proprietary gene control platforms.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Syros Pharmaceuticals
Sector Overlap
Both Syros Pharmaceuticals and 23andMe operate in Biotech.
Browse all Biotech companies →